SEARCH UNITED KINGDOM ABOUT PRODUCT INFORMATION RESPONSIBILITY Investors Careers Contact Us Home Page Responsibility Financial Disclosures Financial Disclosures 2019 FINANCIAL DISCLOSURES 2019 Celgene provides financial support to a range of organisations and initiatives that make a positive impact on our patients, our communities and our world, today and for years to come. We are committed to improving the lives of patients and focus our support in areas where we can make the greatest impact. Payments to Patient Groups In 2019, Celgene provided payments to, or on behalf of, the following patient groups in the UK: Bike the UK for MS Sponsorship of Bike the UK for MS 2019/20 £ 5,000 Crohn’s & Colitis UK Grant to support the development of an animated patient video on managing fatigue £ 5,000 Funding towards the development of patient videos speaking about living living with Crohn’s and Colitis £ 3,279.88 International Brain Tumour Alliance (IBTA) Donation towards International Brain Tumour Alliance Fourth Biennial World Summit of Brain Tumour Patient Advocates $ 8,500 Leukaemia Care Grant towards Leukaemia Care core services including; buddy service, counselling service, welfare advice service and hospital travel £ 25,000 Lymphoma Action Grant to support core information and support services for people who are affected with Lymphatic cancer including: patient information, education programmes, information and support helpline and education programme for healthcare professionals £ 20,000 Multiple Sclerosis International Federation Grant towards 2019 informed decision-making resources: website, newsletters, publications, care and support network $ 7,500 Grant towards 2019 Atlas of MS, global, open-access source of data on MS $ 15,000 Grant towards 2019 World MS Day $ 15,000 Grant towards 2019 MSIF Capacity Building to support, train and develop MS patient organisations all over the world and Kiss Goodbye to MS campaign, a programme to support those who raise funds to beat the disease $ 37,500 MS Trust Medical Information stand at MS Trust Annual Conference 3-5th November 2019 £ 2,100 Myeloma UK Donation towards Celgene employees’ sponsorship of Myeloma UK London to Paris Bike Ride 2019 £ 1,001.81 Sponsorship and entry fee for ten riders to take part in Myeloma UK London to Paris Bike Ride 2019 £ 10,000 Grant towards Myeloma UK core services including; patient and family information and support, healthcare professional programme and health services research £ 110,000 Entry fee for additional three riders to take part in Myeloma UK London to Paris Bike Ride 2019 £ 2,827 Pancreatic Cancer UK Grant towards Pancreatic Cancer UK’s Annual Summit £20,000 Patient Evidence Consultancy fees towards the review of lenalidomide patient summary £ 400 Psoriasis Association Funding towards Psoriatic Disease Policy Scorecard Collaborative Project £ 2,400 Grant to support media training £ 2,850 SANE 2019 Corporate Donation £ 26,828.99 UK Thalassaemia Society Grant to support Patient Support Programme, UKTS Magazine and School Education Programme £ 15,000 World Child Cancer 2019 Donation to World Child Cancer $ 100,000 Financial disclosures for 2020 Financial disclosures for 2018 NP-UK-NA-1057 Date of preparation: March 2020 Font Size Responsibility Financial Disclosures Financial Disclosures 2019 Financial Disclosures 2018 UK Modern Slavery Act Statement EFPIA Spend Transparency Disclosure Celgene UK Group Tax Strategy 2020 Joint Working Funding GLOBAL OFFICE LOCATIONS HAVE A QUESTION OR CONCERN? CONTACT US ABOUT PRODUCT INFORMATION RESEARCH & DEVELOPMENT RESPONSIBILITY PATIENTS HEALTHCARE PROFESSIONALS INVESTORS CAREERS PIPELINE PRIVACY POLICY LEGAL NOTICE SITE MAP COPYRIGHT © 2021 CELGENE CORPORATION A BRISTOL-MYERS SQUIBB COMPANY PRIVACY POLICY LEGAL NOTICE COOKIES POLICY Celgene is a Bristol-Myers Squibb company Select CONTINUE for information about Celgene. Select BMS to learn more about Bristol Myers Squibb. CONTINUE BMS We use cookies to improve the website and your navigation experience based on our Privacy Policy and Legal Notice. To accept cookies continue to browse the site or click the button. For more information on how we use cookies and how to disable them, please visit our Cookies PolicyOk Cookie Preferences